InsidersTradesSigma
Expres2ion Biotech Holding AB: directors' dealings · Finland · FIN-FSA
FI:expres2ion-biotech-holding-ab-5f5408SE0028501155FI·FIN-FSAMcap 21M€Healthcare
Explore the full insider trade history of Expres2ion Biotech Holding AB, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Expres2ion Biotech Holding AB has logged 3 insider filings. Market capitalisation: €20.7m. The latest transaction was filed on 6 May 2026 (Purchase). Among the most active insiders: Jakob Knudsen. All data is accessible without an account.
3
Insider Decl.
0
Thresholds
€38,078
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.09 €
Analyst consensus
1 analystsStrong buy
6.00 €Target 6.00 €(+187%)6.00 €
Income statement
Revenue3.7 M€
Gross profit137 k€4% margin
Net income−38.1 M€-1041.4% margin
Valuation
PER (forward)-0.1x
P/Book0.2x
Beta2.20
Balance sheet & cash
Market cap20.7 M€
Total debt501 k€
Free Cash Flow−40.9 M€
Debt / Equity4%
Profitability & ownership
ROE-88.0%
ROA-40.4%
% insiders0.7%
% institutions0.0%
Last declaration on 6 May 2026
Declarations0 total
No declarations found
0 of 0 declarations